Barinthus Biotherapeutics (BRNS) Other Operating Expenses (2022 - 2026)
Barinthus Biotherapeutics' (BRNS) quarterly Other Operating Expenses came in at $46000.0 in Q1 2026, down 86.02% YoY from $329000.0 in Q1 2025, and up 475.0% on a QoQ basis from $8000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Other Operating Expenses (2022 - 2026) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 4 years of Other Operating Expenses data on file, last reported at $46000.0 in Q1 2026.
- Quarterly Other Operating Expenses fell 86.02% year-over-year to $46000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $223000.0 (down 82.85% YoY) and the FY2025 annual result came in at $506000.0, down 56.97% from the prior year.
- Other Operating Expenses grew to $46000.0 in Q1 2026, from $8000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $19.4 million in Q4 2022 to a low of -$10.8 million in Q3 2022.
- A 4-year average of $365500.0 and a median of $170000.0 in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 60.49% in 2025, down 97.75% in 2025.
- Tracing BRNS's Other Operating Expenses over 4 years: stood at $19.4 million in 2022, then slumped by 99.05% to $184000.0 in 2024, then sank by 95.65% to $8000.0 in 2025, then soared by 475.0% to $46000.0 in 2026.
- The last three Other Operating Expenses figures came in at $46000.0 (Q1 2026), $8000.0 (Q4 2025), and $156000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Barinthus Biotherapeutics | 25.40 Mn | 25.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 329,000.00 |
| Dec 31, 2024 | 184,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Jun 30, 2024 | 577,000.00 |
| Mar 31, 2024 | 205,000.00 |
| Dec 31, 2022 | 19.37 Mn |
| Sep 30, 2022 | -10.82 Mn |
| Jun 30, 2022 | -5.89 Mn |